Encompass Health (NYSE:EHC) Stock, Quote.Headers.trade-ideas

Encompass Health

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Large Cap

News

Dividends

Markets

Trading Ideas

ETFs

JNPR

O'Shares FTSE Russell Small Cap Quality Dividend ETF

OUSM

Making its debut on 12/30/2016, smart beta exchange traded fund ALPS O&#39;Shares U.S. Small-Cap Quality Dividend ETF (BATS: OUSM) provides investors broad exposure to the Style Box - Small Cap Blend category of the market.

Is ALPS O&#39;Shares U.S. Small-Cap Quality Dividend ETF a Strong ETF Right Now?

Earnings

Earnings Beats

Health Care

Small Cap

Analyst Ratings

General

LNTH

The Cigna Group (NYSE: CI) continues to be aided by two solid growth platforms, acquisitions and a solid financial position. A solid 2024 guidance also acts as an additional tailwind for the stock. 

Compelling Reasons to Hold on to Cigna Stock for Now

Humana Inc. (NYSE: HUM) recently entered into an in-network deal with The University of Alabama at Birmingham (&#34;UAB&#34;) Health System in a bid to provide HUM&#39;s Medicare Advantage members in Alabama greater access to care. The agreement came into effect earlier this year.

Humana Partners With UAB to Boost Care for MA Members

Encompass Health Corporation Common Stock

Encompass Health Corp

WIIM

EHGO

Eshallgo shares are trading higher. The company announced it secured $5 million through a convertible debenture offering.

Adds scale and extends Ready Capital's core platform with UDF IV's proven land development lending platform
Diversifies Ready Capital's portfolio and offers land development solution to borrowers and investors
Expected to be accretive to Ready Capital's earnings and book value in 2025 UDF IV shareholders may receive up to $5.89 per UDF share through a combination of: (i) pre-closing distributions of UDF IV's own cash from its balance sheet valued at up to $75 million, or $2.44 per share, (ii) shares issued at closing by Ready Capital for UDF IV shares valued at $94 million, or $3.07 per share, and (iii) contingent value rights with estimated future value of up to $12 million, or $0.38 per share
NEW YORK and IRVING, Texas, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Ready Capital Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RC#NYSE">RC</a>) ("Ready Capital"), a multi-strategy real estate finance company that originates, acquires, finances and services lower-to-middle-market investor and owner-occupied commercial real estate loans, and United Development Funding IV ("UDF IV" or the "Trust"), a real estate investment trust providing capital solutions to residential real estate developers and regional homebuilders, announced today that they have entered into a definitive merger agreement pursuant to which Ready Capital will acquire UDF IV. Upon completion of the transaction, Ready Capital is anticipated to have a pro forma equity capital base in excess of $2.2 billion.

Ready Capital And United Development Funding IV Announce Definitive Agreement For Ready Capital To Acquire United Development Funding IV; UDF IV Shareholders May Receive Up To $5.89 Per UDF

ELUT

Elutia Secures National Agreement With Premier For Cardiac Rhythm Management Devices, Offering Special Pricing On EluPro Antibiotic-Eluting BioEnvelope To Premier Members; Financial Terms Not Disclosed

Management

SNBR

Stadium Capital Management Nominates Four Director Candidates - Patrick A. Hopf, Jeffrey T. Jackson, Jessica M. Prager And Kevin Baker - To Sleep Number's Board

NRIX

Nurix Therapeutics shares are trading higher after the company announced it will present its Phase 1 clinical trial cancer data for BTK Degrader NX-5948.

Acquisition expands cloud and AI technology services and solutions
CDW (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDW#NASDAQ">CDW</a>), a leading multi-brand provider of information technology solutions to business, government, education and healthcare customers in the United States, the United Kingdom and Canada, today announced that it has acquired Mission Cloud Services Inc., a leading cloud professional services, managed services and consulting provider. The transaction complements CDW Digital Velocity – CDW's cloud, data, AI and software platform engineering organization – while bolstering CDW's existing cloud expertise, market scale and solution capabilities. Mission and CDW will come together as CDW's dedicated AWS practice.

CDW Announces Acquisition Of Mission Cloud Services; No Financial Terms Disclosed

President-elect Donald Trump's recent nominations for key law enforcement roles suggest a pivot in federal drug enforcement with potential ramifications for <a href="https://www.benzinga.com/topic/cannabis-legalization">cannabis legalization policy</a>. 
Trump <a href="https://www.benzinga.com/news/24/12/42256740/trump-taps-loyalist-patel-for-fbi-director-signaling-major-overhaul">nominated</a> Kash Patel, a former national security official, to lead the FBI and Chad Chronister, a Florida sheriff, as administrator of the Drug Enforcement Administration (DEA). Both appointments, subject to Senate confirmation, align with Trump&#8217;s broader law-and-order agenda.
<h2 class="wp-block-heading">Kash Patel's FBI Overhaul</h2>
Patel's vision for the FBI involves a sweeping restructuring, which includes dismantling its intelligence-gathering functions and purging its ranks of employees who are viewed as disloyal to Trump, including the media.
He has proposed reforms that could impact how federal resources are allocated to drug enforcement, including cannabis-related offenses. Under his leadership, the FBI may narrow its focus on significant criminal cases, potentially reducing its involvement in low-level marijuana possession enforcement. 
Though it could also work out, at least in the short term, that Patel will be busy chasing down conspirators in the <a href="https://www.benzinga.com/topic/biden-administration">Biden administration</a> and the media.
"We're going to come after the people in the media who lied about American citizens who helped Joe Biden rig presidential elections," Patel told Steve Bannon in a podcast last December.
And did we mention that Patel wrote a trilogy of children's books about Trump called "The Plot Against the King" featuring Trump as a fairy tale monarch and Patel as a knight in his service?
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/41034042/fbi-report-over-200-000-people-were-arrested-for-cannabis-related-violations-in-2023-how-is-that">FBI Report Over 200,000 People Were Arrested For Cannabis-Related Violations In 2023: How Is That Possible?</a> 
<h2 class="wp-block-heading">DEA Leadership And Cannabis Enforcement</h2>
Chronister's nomination as DEA chief underscores a strong focus on combating drug trafficking, particularly <a href="https://www.benzinga.com/topic/fentanyl">fentanyl</a> and other opioids. 
In a Truth Social post on Saturday, Trump <a href="https://truthsocial.com/@realDonaldTrump/posts/113574561799756610">said</a> Chronister will work with his <a href="https://www.benzinga.com/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform" target="_blank" rel="noreferrer noopener">attorney general nominee Pam Bondi</a> to help secure the U.S.-Mexico Border. Chronister replied that he was honored and &#8220;deeply humbled by this opportunity to serve our nation.&#8221;
As a sheriff, Chronister has shown support for decriminalizing cannabis in the past but did not publicly support or malign Florida's recent <a href="https://www.benzinga.com/markets/cannabis/24/11/41763514/florida-rejects-cannabis-legalization-amendment-supported-by-trump-detested-by-desantis">unsuccessful Amendment 3 </a>proposal to legalize marijuana. 
However, if approved, it seems Chronister's marching orders will be to prioritize high-level trafficking and leave lower-level cannabis offenses to state and local authorities while maintaining the <a href="https://www.benzinga.com/markets/cannabis/24/01/36624064/deas-cannabis-classification-time-to-right-a-decades-old-mistake-as-feds-confirm-marijuanas-medi">DEA's historical stance</a> against federal cannabis legalization.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42220254/dea-sets-stage-for-marijuana-rescheduling-with-december-2-hearing">DEA Sets Stage For Marijuana Rescheduling With December 2 Hearing</a></li>
</ul>
Photo: Courtesy DEA, FBI

Cannabis

Government

Politics

Legal

Trump's Kash Patel FBI Pick And DEA Nominee Could Signal Shift In Drug Enforcement Priorities

MARA Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) has announced another private offering of $700 million of zero-coupon convertible senior notes due 2031 after completing <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42066506/bitcoin-mining-stock-mara-holdings-is-moving-higher-whats-going-on">a $1 billion offering of 0% convertible senior notes</a> due 2030 in November.
What Happened: The notes will be offered to qualified institutional buyers with 0% interest and no accretion of principal, as per the company&#8217;s press release. The interest rate, initial conversion rate, and other terms of the notes will be determined at the time of pricing of the offering.
The current offering will also be primarily to acquire bitcoin and repurchase existing convertible notes due 2026.
The conversion price of $1 billion notes that were offered to the investors in November represented a premium of approximately 42.5% over the Nov. 18 mid-day share price of $18.1848.
From the previous offering after deducting the initial purchasers' discounts and commissions MARA raised approximately $980 million. Of that, it used $199 million to repurchase $212 million in aggregate principal amount of its existing convertible notes due 2026. The remainder of the net proceeds were used to acquire additional Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and for general corporate purposes.
Also read: <a href="https://www.benzinga.com/markets/equities/24/12/42260202/goldman-sachs-morgan-stanley-bank-of-montreal-cut-positions-in-marvell-technology-invesco-t-rowe-price-doubled-down">Goldman Sachs, Morgan Stanley, Bank Of Montreal Cut Positions In Marvell Technology — Invesco, T. Rowe Price Doubled Down</a>
Why It Matters: A convertible note is a hybrid instrument that can be exchanged for equity in the company at a later date. These convertible notes, even though with 0% interest, still favor investors in the event of bankruptcy as bondholders are given repayment priority ahead of shareholders.
At the same time, the conversion feature of these notes eventually helps the debt holders to participate in the equity upside on conversion.
MicroStrategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) has also been issuing 0% convertible notes to acquire cryptocurrency lately. Michael Saylor shared MARA&#8217;s update and said it is a &#8220;company on the Bitcoin Standard.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24MARA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$MARA</a> is a company on the <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> Standard. <a href="https://t.co/bk8dBbQaqM">https://t.co/bk8dBbQaqM</a>
&mdash; Michael Saylor&#x26a1;&#xFE0F; (@saylor) <a href="https://twitter.com/saylor/status/1863552025415364956?ref_src=twsrc%5Etfw">December 2, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Also read: <a href="https://www.benzinga.com/markets/equities/24/11/42186167/michael-saylors-microstrategy-convertible-notes-to-buy-bitcoin-offer-no-interest-so-why-are-investors-rushing-to-buy-them">Michael Saylor&#8217;s MicroStrategy Convertible Notes To Buy Bitcoin Offer No Interest, So Why Are Investors Rushing To Buy Them?</a>
MARA&#8217;s Current Bitcoin Holdings
According to <a href="https://www.coingecko.com/en/public-companies-bitcoin">Benzinga Pro</a>, as of Dec. 2, the company held 26,842 Bitcoins valued at $2.54 billion, representing an average price of $94,96.
Price Action: Shares of MARA were down 1.97% at $26.88 per share in premarket on Monday. Nasdaq 100 futures were 0.04% up at 21,005.25 points.
On a year-to-date basis, the Nasdaq 100 Index is up 26.51% in 2024, while MARA underperformed the gauge with 19.58% growth in the same period. Apart from this, MARA was up 40.04% and 76.90% in the last six months and one month, respectively.
According to <a href="https://www.benzinga.com">Benzinga</a>, MARA has a consensus price target of $23.83 per share based on the ratings of 17 analysts. The highest price target out of all the <a href="https://www.benzinga.com/quote/MARA/analyst-ratings">analysts tracked by Benzinga</a> is $66 apiece issued by Compass Point as of March 8, 2022. The lowest target price is $4 per share issued by Jefferies on Jan. 9, 2023.
The average price target of $27 apiece between Barclays, Compass Point, and Macquarie implies a 0.18% downside for MARA.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/MARA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="382" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02081953/MARA-ANR-1024x382.png" alt="" class="wp-image-672300" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02081953/MARA-ANR-1024x382.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02081953/MARA-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02081953/MARA-ANR-768x286.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02081953/MARA-ANR.png 1057w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read next: <a href="https://www.benzinga.com/24/12/42260627/south-korea-gets-its-first-unicorn-of-2024-as-china-based-alibaba-invests-714m-in-ably-corp">Alibaba&#8217;s $71M Bet On Ably Corp Turns It Into South Korea&#8217;s First Unicorn of 2024</a>
Image via Pixabay

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

$BTC

MARA

MSTR

MARA Targets BTC And Debt Buybacks With New $700M Convertible Notes Offering: MSTR's Michael Saylor Says It Is 'A Company On The Bitcoin Standard'

PPBT

Purple Biotech shares are trading higher after the company announced final results from the randomized Phase 2 study of its lead oncology drug, CM24 in patients with pancreatic ductal adenocarcinoma.

SNTI

Senti Biosciences shares are trading higher after the company announced a private investment in public equity to issue and sell an aggregate of 16,713 shares of Series A Convertible Preferred Stock.

JP Morgan analyst Reginald Smith maintains Kaspi.kz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSPI#NASDAQ">KSPI</a>) with a Overweight and lowers the price target from $154 to $137.

Price Target

KSPI

JP Morgan Maintains Overweight on Kaspi.kz, Lowers Price Target to $137

OLMA

Olema Pharmaceutical shares are trading higher after the company announced a new clinical trial collaboration and supply agreement with Novartis for frontline metastatic breast cancer. Also, the company entered into a private placement of common stock worth $250 million.

Future Fintech Group Inc. (NASDAQ:&nbsp;<a href="https://www.ftft.com/en/">FTFT</a>), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technology service provider, today announced an update of the Company's Blockchain Business Division. The division was established in December 2021 to manage its existing blockchain business to include its development as well as the execution of its strategic growth plan.
&nbsp;
The new focus of the Blockchain Business Division will be to develop and grow new blockchain businesses such as high-performance computing, web3 technology, artificial intelligence (AI), and other blockchain related projects. The Blockchain Business Division will continue to manage its existing businesses to include coordinating its operations, developing business synergies and executing on its strategic growth plan.

FTFT

Future FinTech Announces An Update Of Its Blockchain Division,  To Develop And Grow New Blockchain Businesses Such As High-Performance Computing, Web3 Technology, AI, And Other Blockchain Related Projects

Nano Labs Announces $50M Bitcoin Purchase Plan Over Five Years To Strengthen Market Position And Support Web 3.0 Ecosystem Growth

MDJH

MDJM LTD Announces Ticker Symbol Change To 'UOKA' Effective Dec. 3rd

Cloudflare shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its p[rice target from $92 to $130.

Letter calls on National Community Investment Fund, Bank of America, J.P. Morgan, American Express and other community-focused investors to help drive improved performance
Says continued support of under-performing Board does the community and Carver no good
Urges all shareholders to vote for change: Vote FOR Mr. Jeffrey "Jeff" Anderson and Mr. Jeffrey Bailey for the Board of Directors using the BLUE proxy card and vote WITHHOLD on Carver's under-performing Directors
ISS finds that Carver's "long history of TSR and operational underperformance suggest that the bank needs to rethink its strategy and its approach to execution"
NEW YORK, Dec. 2, 2024 /PRNewswire/ -- Dream Chasers Capital Group LLC ("Dream Chasers") today called on large financial institutions and funds that have invested in Carver Bancorp, Inc. ("Carver," or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARV#NASDAQ">CARV</a>) to support nominees that will drive change on the Carver Board of Directors (the "Board"). While these investors' support of Carver over the years has been admirable, we can all agree it is counterproductive to support a Board that has presided over a prolonged period of poor performance.

CARV

Dream Chasers Urges Institutional Shareholders To Join Retail Holders To Drive Change At Carver; Letter Calls On National Community Investment Fund, Bank Of America, J.P. Morgan, American Express And Other Community-Focused Investors To Help Drive Improved Performance

JP Morgan analyst Reginald Smith maintains SoFi Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) with a Neutral and raises the price target from $9 to $16.

SOFI

JP Morgan Maintains Neutral on SoFi Techs, Raises Price Target to $16

SPAI

Safe Pro's Airborne Response Completes Milestones For Florida Police Drone Contract, Delivering Drone-As-A-First-Responder Solution With FAA Coordination, 24/7 Operations Training, And Advanced Drone Nest Technology

OKTA

Okta shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $92 to $97.

Barclays raised the firm's price target on Encompass Health (EHC) to $116 from $109 and keeps an Overweight rating on the shares post the Q3 report...

Encompass Health price target raised to $116 from $109 at Barclays

KeyBanc raised the firm's price target on Encompass Health (EHC) to $117 from $115 and keeps an Overweight rating on the shares. The firm says Q3 r...

Encompass Health price target raised to $117 from $115 at KeyBanc

Analyst Whit Mayo from Leerink Partners reiterated a Buy rating on Encompass Health (EHC – Research Report) and keeping the price target at $102.00...

Encompass Health's Strong Q3 Performance and Raised 2024 Guidance Drive Buy Rating

Bank of America Securities analyst Joanna Gajuk maintained a Buy rating on Encompass Health (EHC – Research Report) today. The company's shares ope...

Bank of America Securities Keeps Their Buy Rating on Encompass Health (EHC)

Encompass Health Corporation (EHC) Q3 2024 Earnings Call Transcript

In a report released today, Ben Hendrix from RBC Capital reiterated a Buy rating on Encompass Health (EHC – Research Report), with a price target o...

RBC Capital Reaffirms Their Buy Rating on Encompass Health (EHC)

Truist raised the firm's price target on Encompass Health (EHC) to $116 from $108 and keeps a Buy rating on the shares. The company reported strong...

Encompass Health price target raised to $116 from $108 at Truist

Invesco Discovery Fund Q3 2024 Commentary

Invesco Discovery Mid Cap Growth Fund Q3 2024 Commentary

Janus Henderson Global Sustainable Equity ADR Managed Account Q3 2024 Commentary

ALGM

ARES

AXON

BKLN

BOOT

CFLT

CQQQ

CWAN

CYBR

DUOL

DXCM

ENTG

FORM

GDDY

GWRE

HLNE

JAAA

JBBB

JMBS

JSMD

JSML

KBWB

KBWD

KBWY

LPLA

MCHP

MEDP

MPWR

MSFT

NVDA

PCEF

PDBC

PNQI

PRFZ

QQQJ

QQQM

RSPT

SBGSF

SITM

SOXQ

SPGP

SPHB

SPHD

SPHQ

SPLV

SPMO

SSEZF

SSEZY

TMUS

TRGP

VNLA

WFRD

WING

XMMO

Press Releases

Encompass Health increases and declares dividend on common stock and announces increase in common stock repurchase authorization

Encompass Health Rehabilitation Hospital of Johnston, a 50-bed inpatient rehabilitation hospital, now open in Rhode Island

Encompass Health reports results for second quarter 2024

Encompass Health Rehabilitation Hospital of Fort Mill Now Open in South Carolina

Encompass Health Announces Date of 2024 Third Quarter Earnings Call

Encompass Health Declares Dividend on Common Stock

Offerings

Encompass Health Issues Notice for Partial Redemption of Its 5.75% Senior Notes Due 2025

Encompass Health reports results for third quarter 2024

Encompass Health Announces Preliminary Plans to Build a 50-bed Inpatient Rehabilitation Hospital in Wesley Chapel

Encompass Health Rehabilitation Hospital of Houston at The Medical Center Now Open in Texas

Comments

Encompass Health

Encompass Health (EHC) Forecast

Encompass Health (NYSE:EHC) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga